Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 Msec

Clinical trial NCT00879242 · COMPLETED

Trial details

NCT number: NCT00879242
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Beta Thalassemia Transfusion Dependent

Start date: 2009-02-01
Primary completion: 2011-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.